Diclofenac-hydrotalcite: In vitro and in vivo release experiments
Source abstract
Abstract
Solutions of the anti-inflammatory drug diclofenac in ethanol and ethanol-water were prepared and mixed with hydrotalcite and hydrotalcite heated at 500 degrees C. Hydrotalcite pretreated at 500 degrees C showed a higher adsorption of diclofenac. Diclofenac-hydrotalcites were used for in vitro release experiments to evaluate the percutaneous absorption of diclofenac, using sets of eight Franz cells with membranes of stratum corneum epidermis obtained from human skin; a 2% diclofenac hydroalcoholic gel was used for comparison. Hydrotalcite pretreated at 500 degrees C is less suitable for release procedures, despite its higher adsorption capacity, whereas diclofenac adsorbed from ethanolic solution by untreated hydrotalcite presents the most efficient sample and shows the best permeation profiles. This sample was selected for the in vivo experiments. Ten healthy volunteers participated on the in vivo experiments: the diclofenac-hydrotalcite appeared to be useful for an efficient application on human skin as inhibitor of the UV-induced erythemas, also better than the usual gel samples.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Layered Double Hydroxides Synthesis and Applications · Mesoporous Materials and Catalysis · Synthesis and properties of polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (27)
Show source-provided references
1. Use of clays as drug delivery systems: Possibilities and limitations10.1016/j.clay.2006.06.015 ↗
2. Intercalation compounds of hydrotalcite-like anionic clays with anti-inflammatory agents, II: uptake of diclofenac for a controlled release formulation10.1007/BF02830624 ↗
3. Clay minerals and their beneficial effects upon human health10.1016/S0169-1317(01)00085-0 ↗
4. Clays and Human Health
5. Synthesis and characterization of layered double hydroxides (LDH) intercalated with non-steroidal anti-inflammatory drugs (NSAID)10.1016/j.jssc.2004.08.006 ↗
6. Fate and mobility of pharmaceuticals in solid matrices10.1016/j.chemosphere.2005.01.032 ↗
7. The validity and practicality of sun-reactive skin types I through IV10.1001/archderm.124.6.869 ↗
8. Layered Double Hydroxides
9. Immobilization of ibuprofen and copper-ibuprofen drugs on layered double hydroxides10.1002/jps.20336 ↗
10. Synthesis and photochemical properties of zinc–aluminum layered double hydroxide/organic UV ray absorbing molecule/silica nanocomposites10.1016/j.jpcs.2003.08.031 ↗
11. Oral versus topical NSAIDs in rheumatic disease: a comparison10.2165/00003495-200060030-00004 ↗
12. Unit cell refinement from powder diffraction data: the use of regression diagnostics10.1180/minmag.1997.061.404.07 ↗
13. Aspekte zur ausscheidumg antimikrobiell wirksamer substanzen nach der chemotherapeutischen behandlung von nutztieren
14. The influence of hydrotalcite and cancrinite-type zeolite in acidic aspirin solutions10.1016/j.micromeso.2004.05.016 ↗
15. Anionic Clays Containing Anti-Inflammatory Drug Molecules: Comparison of Molecular Dynamics Simulation and Measurements10.1021/jp050480m ↗
16. Transdermal delivery of diclofenac sodium through rat skin from various formulations10.1208/pt070488 ↗
17. Thermal decomposition of hydrotalcites: an infrared and nuclear magnetic resonance spectroscopic study10.1039/FT9928802233 ↗
18. On the structure of activated hydrotalcites as solid base catalysts for liquid-phase aldol condensation10.1006/jcat.2001.3295 ↗
19. Intercalation of the radical scavenger ferulic acid in hydrotalcite-like anionic clays10.1016/j.ijpharm.2005.01.040 ↗
20. A comparison of the in vitro permeability properties of human and some laboratory animal skins10.1111/j.1467-2494.1986.tb00446.x ↗
21. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms10.1208/pt040107 ↗
22. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems10.1016/j.ijpharm.2005.12.019 ↗
23. The present status of anti-inflammatory agents in dermatology10.2165/00003495-198800365-00009 ↗
24. Release characteristics of diclofenac sodium from encapsulated natural gum mini-matrix formulations10.1016/0378-5173(96)04573-5 ↗
25. Intercalation compounds of layered materials for drug delivery use: II. Diclofenac sodium10.1248/cpb.49.964 ↗
26. Altered skin permeation of a highly lipophilic molecule: tetrahydrocannabinol10.1016/0378-5173(88)90053-1 ↗
27. Studies on the intercalation of naproxen into layered double hydroxide and its thermal decomposition by in situ FT-IR and in situ HT-XRD10.1016/j.jssc.2004.03.041 ↗